Schedule 13G ownership disclosure

ESPERION THERAPEUTICS, INC.

Security class unavailable · CUSIP: 29664W105

Event date: 2023-04-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,314,286
Percent of class
4.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-23-002476
Form type
SC 13G
Filer
Esperion Therapeutics, Inc.
CIK
CIK 1434868
Filed
Apr 05, 2023
Reporting period
Apr 04, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub